COVID paved the way for a new vaccine era

The unprecedented success of the COVID-19 vaccines has elevated the mRNA platform and raised expectations the technology could soon be wielded against other infectious diseases.

The big picture: COVID is still the only disease for which any mRNA vaccines are approved, but dozens more are being developed and tested against the flu, RSV, HIV and even cancer.